Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The IGF/IGFBP system in CNS malignancy.

W Zumkeller1, M Westphal

  • 1Martin-Luther- University Halle-Wittenberg, University Hospital, Department of Pediatrics, Ernst-Grube-Str. 40, 06097 Halle/Saale, Germany. walter.zumkeller@medizin.uni-halle.de

Molecular Pathology : MP
|July 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chytrid infections exhibit historical spread and contemporary seasonality in a declining stream-breeding frog.

Royal Society open science·2024
Same author

Mass producible, robust SERS substrates based on metal film on nanosphere (MFON) on an adhesive substrate for detection of surface-adsorbed molecules and their evaluation by helium ion microscopy.

The Analyst·2023
Same author

Experiences with a 3D4K Digital Exoscope System (ORBEYE) in a Wide Range of Neurosurgical Procedures.

Journal of neurological surgery. Part A, Central European neurosurgery·2022
Same author

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.

Acta neuropathologica communications·2019
Same author

Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.

Parkinsonism & related disorders·2019
Same author

Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease Patients.

Parkinson's disease·2017
Same journal

Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections.

Molecular pathology : MP·2003
Same journal

Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion.

Molecular pathology : MP·2003
Same journal

Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.

Molecular pathology : MP·2003
Same journal

Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong.

Molecular pathology : MP·2003
Same journal

Increased cyclin D1 expression in cancer of the ampulla of Vater: relevance to nuclear beta catenin accumulation and k-ras gene mutation.

Molecular pathology : MP·2003
Same journal

Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.

Molecular pathology : MP·2003
See all related articles

The insulin-like growth factor (IGF) system influences brain tumor growth. Targeting IGF receptors shows promise for treating malignant brain tumors, with ongoing clinical trials.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer research

Background:

  • The insulin-like growth factor (IGF) system, comprising IGF-I, IGF-II, their receptors, and binding proteins, regulates normal and malignant brain growth.
  • Aberrant expression and imprinting of IGF factors and their receptors are implicated in various brain tumors, including gliomas and meningiomas.

Purpose of the Study:

  • To investigate the role of the IGF system in the development and progression of malignant central nervous system (CNS) tumors.
  • To evaluate the therapeutic potential of targeting the IGF system for CNS tumor treatment.

Main Methods:

  • Analysis of IGF-I and IGF-II mRNA expression in brain tumors.
  • Assessment of IGF receptor expression in gliomas.
  • Evaluation of antisense IGF-I receptor mRNA effects on tumor growth in vitro and in vivo.

Related Experiment Videos

  • Measurement of IGF binding proteins (IGFBPs) in cerebrospinal fluid and tumor tissues.

    • Main Results:

    • Enhanced IGF-I and IGF-II mRNA expression and abnormal IGF-II imprinting were observed in brain tumors.
    • Type I IGF receptor is upregulated in malignant brain tissue, and its inhibition via antisense mRNA induced tumor regression.
    • IGFBP-2 is elevated in cerebrospinal fluid of patients with malignant CNS tumors, suggesting its potential as a biomarker.
    • IGFBP-4 may act as a negative regulator of tumor proliferation.

    Conclusions:

    • The IGF system is a critical regulator of malignant CNS tumor growth and represents a significant therapeutic target.
    • Antisense IGF-I receptor strategies show promise for brain tumor treatment, with ongoing clinical trials to validate efficacy.
    • IGFBP-2 may serve as a valuable diagnostic marker for malignant CNS tumors.